Live sessions agenda - ERS Respiratory Channel

2024 - Sleep apnea and its consequences: from animal models to precision medicine

Days (2)

ALL

Thursday, 25.01.2024

Friday, 26.01.2024

Session type (2)

ALL

Session

Welcome

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

2019 - Targeting the detrimental effects of sleep disturbances and disorders ? towards personalized treatment in respiratory diseases

Access older content

2018 - Lung Cancer Screening: from Trial to Practice

2018 - The impact of air pollution on respiratory health ? a focus on persistent problems and new emerging areas

2017 - Immunotherapy: a new standard of care in thoracic malignancies?

2017 - Integrating systems biology approach in idiopathic pulmonary fibrosis research

2017 - Precision medicine in airway diseases

2016 - Pulmonary vascular endothelium: orchestra conductor in respiratory diseases - highlights from basic research to therapy

2016 - New developments in in vitro models of the pulmonary epithelium

2015 - Proteases at the cutting edge: friends or foes in chronic lung diseases?

2016 - Challenges in respiratory medicine: how can we move from symptomatic management to a cure

2015 - Genetics, epigenetics and exposomics: novel methods to study gene-by-environment interactions

2015 - ERS Presidential Summit on personalising respiratory care in Europe

2015 - Targeted therapy for lung cancer

2015 - IPF and cancer: wounds that do not heal

2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

2014 - ERS Presidential Summit on breaking down barriers to lung health

2014 - The many faces of stem cells in respiratory diseases

2014 - Protein quality control in lung disease

2013 - Translational animal models of asthma

2013 - Optimising models for human lung diseases and drug development

2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research

2013 - Sensational developments in the airways: The role of afferent hyper and hypo function in respiratory disease

2012 - Pulmonary inflammation in paediatric respiratory disease

2012 - Dyspnoea: multidimensional and multidisciplinary

2012 - ERS Summit on bridging the health divide in Europe

2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis

2011 - Physical activity, nutritional status and systemic inflammation in COPD

2011 - ERS Summit on priorities in respiratory medicine

2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar

2010 - The role of small airways in obstructive pulmonary diseases

2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

2009 - International seminar on the rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)

2009 - Molecular and Cellular aspects of Chronic Lung Disease

2008 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge

2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases

2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension

2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

2007 - The limits to exercise in COPD: new insights from new methods

2007 - Severe Asthma

2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening

2006 - Complexity of patients with multiple chronic diseases

2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

2005 - Tobacco Smoking: Harm Reduction Strategies

2005 - Smoke Free Europe Conference 2005, jointly organised by ECL, EHN, ERS, French League against Cancer and Cancer Research UK

2005 - Adaptations to Hypoxia

2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases

2004 - The bronchial smooth muscle in airway responsiveness

2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room

2021 - Unravelling severe exacerbations of COPD ? CICERO an ERS CRC

2021 - Lung function trajectories from birth to death, health and disease, and pre-war to today

2022 - Pharmacology of asthma and COPD: current and future developments

Welcome and introduction by organisers

Welcome

Basic models to explore the deleterious effect of sleep apnoea: Depicting predictors of sleep apnoea-related comorbidities

Chair(s): A. Azarbarzin S. Ryan

Session

Endotypes and susceptibility to the clinical consequences of sleep apnoea

Chair(s): Y. Peker M. Pengo

Session

ERS Assembly 4 Task Force: Upcoming research scenarios

Chair(s): F. Gagnadoux W. Randerath

Session

2024 - Sleep apnea and its consequences: from animal models to precision medicine

#{title}